Targeting viral infection by microRNA inhibition

Genome Biology

Volumn 11, Issue 1, 2010, Pages

  Roberts, Ashley P E ^a   Jopling, Catherine L ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; MEVINOLIN; MICRORNA; MICRORNA 122; MIRAVIRSEN; PLACEBO; PROTEINASE INHIBITOR; RIBAVIRIN; RNA DIRECTED RNA POLYMERASE INHIBITOR; UNCLASSIFIED DRUG; UNTRANSLATED RNA; MIRN122 MICRORNA, HUMAN; OLIGONUCLEOTIDE;

5' UNTRANSLATED REGION; BINDING SITE; CHIMPANZEE; DRUG MEGADOSE; GENE EXPRESSION; HEPATITIS C; HEPATITIS C VIRUS; INTERNAL RIBOSOME ENTRY SITE; LOW DRUG DOSE; NONHUMAN; REVIEW; RNA INTERFERENCE; SEXUAL TRANSMISSION; VIRUS CELL INTERACTION; VIRUS GENOME; VIRUS INFECTION; VIRUS LOAD; VIRUS REPLICATION; ANIMAL; BIOPSY; CLINICAL TRIAL; GENETICS; HUMAN; LIVER; PAN TROGLODYTES; PATHOLOGY; VIROLOGY;

ANIMALS; BIOPSY; CLINICAL TRIALS AS TOPIC; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; LIVER; MICRORNAS; OLIGONUCLEOTIDES; PAN TROGLODYTES;

EID: 77955078117     PISSN: 14747596     EISSN: 1474760X     Source Type: Journal    
DOI: 10.1186/gb-2010-11-1-201     Document Type: Review

References (21)

1. Origins and mechanisms of miRNAs and siRNAs. RW Carthew, EJ Sontheimer, Cell 2009 136 642 655 10.1016/j.cell.2009.01.035 19239886
2. The role of RNAi and microRNAs in animal virus replication and antiviral immunity. JL Umbach, BR Cullen, Genes Dev 2009 23 1151 1164 19451215 10.1101/gad.1793309
3. Hepatitis C virus: the growing challenge. BJ Thomson, Br Med Bull 2009 89 153 167 10.1093/bmb/ldp003 19181740
4. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. RE Lanford, ES Hildebrandt-Eriksen, A Petri, R Persson, M Lindow, ME Munk, S Kauppinen, H Orum, Science 2010 327 198 201 10.1126/science.1178178 19965718
5. Unravelling hepatitis C virus replication from genome to function. BD Lindenbach, CM Rice, Nature 2005 436 933 938 10.1038/nature04077 16107832 (Pubitemid 41191668)
6. miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1. J Chang, E Nicolas, D Marks, C Sander, A Lerro, MA Buendia, C Xu, WS Mason, T Moloshok, R Bort, KS Zaret, JM Taylor, RNA Biol 2004 1 106 113 17179747
7. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. CL Jopling, M Yi, AM Lancaster, SM Lemon, P Sarnow, Science 2005 309 1577 1581 10.1126/science.1113329 16141076 (Pubitemid 41266486)
8. Position-dependent function for a tandem microRNA miR-122-binding site located in the hepatitis C virus RNA genome. CL Jopling, S Schutz, P Sarnow, Cell Host Microbe 2008 4 77 85 10.1016/j.chom.2008.05.013 18621012 (Pubitemid 351944051)
9. Cellular cofactors affecting hepatitis C virus infection and replication. G Randall, M Panis, JD Cooper, TL Tellinghuisen, KE Sukhodolets, S Pfeffer, M Landthaler, P Landgraf, S Kan, BD Lindenbach, M Chien, DB Weir, JJ Russo, J Ju, MJ Brownstein, R Sheridan, C Sander, M Zavolan, T Tuschl, CM Rice, Proc Natl Acad Sci USA 2007 104 12884 12889 17616579 10.1073/pnas.0704894104 (Pubitemid 47255249)
10. microRNA-122 stimulates translation of hepatitis C virus RNA. JI Henke, D Goergen, J Zheng, Y Song, CG Schuttler, C Fehr, C Junemann, M Niepmann, EMBO J 2008 27 3300 3310 19020517 10.1038/emboj.2008.244
11. Silencing of microRNAs in vivo with 'antagomirs'. J Krutzfeldt, N Rajewsky, R Braich, KG Rajeev, T Tuschl, M Manoharan, M Stoffel, Nature 2005 438 685 689 10.1038/nature04303 16258535 (Pubitemid 41740580)
12. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. C Esau, S Davis, SF Murray, XX Yu, SK Pandey, M Pear, L Watts, SL Booten, M Graham, R McKay, A Subramaniam, S Propp, BA Lollo, S Freier, CF Bennett, S Bhanot, BP Monia, Cell Metab 2006 3 87 98 10.1016/j.cmet.2006.01.005 16459310
13. Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver. J Elmen, M Lindow, A Silahtaroglu, M Bak, M Christensen, A Lind-Thomsen, M Hedtjarn, JB Hansen, HF Hansen, EM Straarup, K McCullagh, P Kearney, S Kauppinen, Nucleic Acids Res 2008 36 1153 1162 18158304 10.1093/nar/gkm1113 (Pubitemid 351330933)
14. LNA-mediated microRNA silencing in non-human primates. J Elmen, M Lindow, S Schutz, M Lawrence, A Petri, S Obad, M Lindholm, M Hedtjarn, HF Hansen, U Berger, S Gullans, P Kearney, P Sarnow, EM Straarup, S Kauppinen, Nature 2008 452 896 899 10.1038/nature06783 18368051 (Pubitemid 351550859)
15. Experimental models for hepatitis C viral infection. A Boonstra, LJ van der Laan, T Vanwolleghem, HL Janssen, Hepatology 2009 50 1646 1655 10.1002/hep.23138 19670425
16. Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy. M Sarasin-Filipowicz, J Krol, I Markiewicz, MH Heim, W Filipowicz, Nat Med 2009 15 31 33 10.1038/nm.1902 19122656
17. Mechanisms of antiviral treatment efficacy and failure in chronic hepatitis C. J-M Pawlotsky, Antiviral Res 2003 59 1 11 10.1016/S0166-3542(03) 00088-3 12834855 (Pubitemid 36773885)
18. Hepatitis C drug development at a crossroads. DR Nelson, Hepatology 2009 50 997 999 10.1002/hep.23208 19787813
19. Modulation of hepatitis C virus RNA abundance and the isoprenoid biosynthesis pathway by microRNA miR-122 involves distinct mechanisms. KL Norman, P Sarnow, J Virol 84 666 670 10.1128/JVI.01156-09 19846523
20. miR-122 targeting with LNA/2'-O-methyl oligonucleotide mixmers, peptide nucleic acids (PNA), and PNA-peptide conjugates. MM Fabani, MJ Gait, Rna 2008 14 336 346 18073344 10.1261/rna.844108 (Pubitemid 351171593)
21. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. MS Ebert, JR Neilson, PA Sharp, Nat Methods 2007 4 721 726 10.1038/nmeth1079 17694064 (Pubitemid 47338166)